Related Experiment Video

Updated: May 8, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

Treating methicillin-resistant Staphylococcus aureus infections with compounded vancomycin preparations

Linda F McElhiney1

  • 1Clarian Health Partners, Inc., Indianopolis, Indiana.

International Journal of Pharmaceutical Compounding
|August 24, 2013
PubMed

Insights

Methicillin-Resistant Staphylococcus aureus (MRSA) infections are a growing threat in both hospitals and communities. Compounding pharmacists can aid in developing novel MRSA therapies and patient counseling to combat rising drug resistance.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Antimicrobial Resistance

Background:

  • Methicillin-Resistant Staphylococcus aureus (MRSA) presents a significant and escalating challenge in healthcare settings.
  • The prevalence of MRSA infections has expanded from institutional environments into the community.
  • Rapid development of antimicrobial resistance complicates the creation of effective treatment strategies.

Purpose of the Study:

  • To explore the role of compounding pharmacists in managing Methicillin-Resistant Staphylococcus aureus infections.
  • To identify how pharmacists can support physicians in developing new therapeutic approaches for MRSA.
  • To highlight the importance of patient counseling in MRSA infection prevention.

Main Methods:

  • Literature review on MRSA treatment challenges and antimicrobial resistance patterns.
  • Analysis of the potential contributions of pharmaceutical compounding to novel drug delivery systems.
  • Examination of pharmacist-led patient education strategies for infection control.

Main Results:

  • Compounding pharmacists can create customized dosage forms and innovative therapies to address MRSA.
  • Pharmacist involvement can lead to more effective and personalized treatment plans for MRSA patients.
  • Patient counseling by pharmacists is crucial for preventing the spread of MRSA infections.

Conclusions:

  • Compounding pharmacists are vital allies in the fight against Methicillin-Resistant Staphylococcus aureus.
  • Collaboration between pharmacists and physicians can yield improved outcomes for MRSA infections.
  • Enhanced patient education and tailored pharmaceutical interventions are key to combating MRSA.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...